1. Home
  2. MRVI vs RXT Comparison

MRVI vs RXT Comparison

Compare MRVI & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • RXT
  • Stock Information
  • Founded
  • MRVI 2014
  • RXT 1998
  • Country
  • MRVI United States
  • RXT United States
  • Employees
  • MRVI 560
  • RXT N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • RXT EDP Services
  • Sector
  • MRVI Health Care
  • RXT Technology
  • Exchange
  • MRVI Nasdaq
  • RXT Nasdaq
  • Market Cap
  • MRVI 350.1M
  • RXT 280.1M
  • IPO Year
  • MRVI 2020
  • RXT 2020
  • Fundamental
  • Price
  • MRVI $2.42
  • RXT $1.26
  • Analyst Decision
  • MRVI Hold
  • RXT Hold
  • Analyst Count
  • MRVI 10
  • RXT 5
  • Target Price
  • MRVI $5.84
  • RXT $1.58
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • RXT 764.7K
  • Earning Date
  • MRVI 08-11-2025
  • RXT 08-07-2025
  • Dividend Yield
  • MRVI N/A
  • RXT N/A
  • EPS Growth
  • MRVI N/A
  • RXT N/A
  • EPS
  • MRVI N/A
  • RXT N/A
  • Revenue
  • MRVI $219,830,000.00
  • RXT $2,693,100,000.00
  • Revenue This Year
  • MRVI N/A
  • RXT N/A
  • Revenue Next Year
  • MRVI $7.23
  • RXT $1.48
  • P/E Ratio
  • MRVI N/A
  • RXT N/A
  • Revenue Growth
  • MRVI N/A
  • RXT N/A
  • 52 Week Low
  • MRVI $1.67
  • RXT $1.00
  • 52 Week High
  • MRVI $9.60
  • RXT $3.41
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • RXT 52.70
  • Support Level
  • MRVI $2.28
  • RXT $1.14
  • Resistance Level
  • MRVI $2.47
  • RXT $1.31
  • Average True Range (ATR)
  • MRVI 0.14
  • RXT 0.08
  • MACD
  • MRVI -0.01
  • RXT 0.01
  • Stochastic Oscillator
  • MRVI 27.45
  • RXT 79.55

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: